Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 658.78 M682.63 M653.33 M653 M 2.65 B Research & development ———— — Operating income 215.31 M174.17 M157.4 M123.07 M 669.95 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income 215.44 M174.11 M158.09 M123.65 M 671.28 M Equity in earnings ———— — Taxes 51.71 M44.91 M37.97 M33.83 M 168.42 M Non-controlling/minority interest ———— — After tax other income/expense -1.78 M-497 K1.07 M-3.08 M -4.29 M Net income before discontinued operations 163.72 M129.19 M120.12 M89.83 M 502.86 M Discontinued operations ———— — Net income 163.72 M129.19 M120.12 M89.83 M 502.86 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 163.72 M129.19 M120.12 M89.83 M 502.86 M Basic earnings per share (Basic EPS) 1.731.371.230.93 5.26 Diluted earnings per share (Diluted EPS) 1.711.371.220.93 5.23 Average basic shares outstanding 94.81 M93.99 M97.67 M97.69 M — Diluted shares outstanding 95.58 M94.41 M98.72 M98.7 M — EBITDA 260.74 M220.61 M199.6 M165.69 M 846.64 M EBIT 216.47 M174.93 M158.86 M123.97 M 674.23 M Cost of revenue 1.41 B1.43 B1.35 B1.33 B 5.52 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 44.28 M45.67 M40.74 M41.72 M 172.41 M